Evidence for a role of cholesterol in HIV-1 trans infection is that enhancing cholesterol efflux in DC by triggering of regulators of cholesterol metabolism, that is, peroxisome proliferator-activated receptor gamma and liver X receptor, decreases HIV-1 trans infection [154]. Here, PPARG is linked to infection.